IGF1R and cancer: If metformin has the same role as rapamycin and its analogs as inhibitor of mTOR, cancer cells may rapidly develop autoresistance to metformin-induced tumoricidal effects due to the negative feedback loop between mTORC1/S6K1 and IGF-1R/IRS-1 (40).